ADC Therapeutics to Join Jefferies Global Healthcare Conference

LAUSANNE, Switzerland, May 30, 2024 – ADC Therapeutics, a prominent company in the field of antibody drug conjugates (ADCs), has announced that its Chief Executive Officer, Ameet Mallik, will provide an overview of the company at the Jefferies Global Healthcare Conference. This presentation is scheduled for Thursday, June 6, 2024, at 11:30 a.m. ET. The event will be streamed live and can be accessed through the ADC Therapeutics' website under the Investors section. The webcast replay will be available for approximately 30 days.

About ADC Therapeutics

ADC Therapeutics is recognized globally as a leader in the creation and commercialization of ADCs. These innovative therapies are designed to target hematologic malignancies and solid tumors more effectively. The company's flagship product, ZYNLONTA (loncastuximab tesirine-lpyl), received accelerated approval from the U.S. Food and Drug Administration (FDA) and conditional approval from the European Commission. It is used for patients with relapsed or refractory diffuse large B-cell lymphoma who have undergone at least two prior systemic treatments. Additionally, ZYNLONTA is being evaluated in combination with other treatments and in earlier stages of therapy. Beyond ZYNLONTA, ADC Therapeutics is actively developing multiple ADCs in both clinical and preclinical stages.

Headquartered in Lausanne, Switzerland, within the Biopôle life sciences campus, ADC Therapeutics also operates facilities in London and New Jersey.

The approval process for ZYNLONTA in China, managed by Overland ADCT BioPharma, and other regulatory approvals in international markets, are also critical. The outcomes of various clinical trials, partnerships for regulatory approvals, and strategic collaborations will influence future success. Financial health and the ability to service debt obligations are also crucial, given the company's indebtedness with institutions like Healthcare Royalty Management, Oaktree, and Blue Owl.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!